Browse by UCL people
Group by: Type | Date
Number of items: 86.
Article
Anstee, QM;
Knapp, S;
Maguire, EP;
Hosie, AM;
Thomas, P;
Mortensen, M;
Bhome, R;
... Thomas, HC; + view all
(2013)
Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibition.
NATURE COMMUNICATIONS
, 4
(ARTN 281)
10.1038/ncomms3816.
|
Arab, Juan Pablo;
Díaz, Luis Antonio;
Rehm, Jürgen;
Im, Gene;
Arrese, Marco;
Kamath, Patrick S;
Lucey, Michael R;
... Mathurin, Philippe; + view all
(2025)
Metabolic Dysfunction and Alcohol-related Liver Disease (MetALD): Position statement by an expert panel on alcohol-related liver disease.
Journal of Hepatology
, 82
(4)
pp. 744-756.
10.1016/j.jhep.2024.11.028.
|
Argemi, J;
Latasa, MU;
Atkinson, SR;
Blokhin, IO;
Massey, V;
Gue, JP;
Cabezas, J;
... Bataller, R; + view all
(2023)
Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis.
Nature communications
, 14
, Article 757. 10.1038/s41467-023-36548-3.
|
Argemi, J;
Latasa, MU;
Atkinson, SR;
Blokhin, IO;
Massey, V;
Gue, JP;
Cabezas, J;
... Bataller, R; + view all
(2019)
Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis.
Nature Communications
, 10
, Article 3126. 10.1038/s41467-019-11004-3.
|
Atkinson, SR;
McQuillin, A;
Morgan, MY;
Thursz, MR;
(2018)
People who survive an episode of severe alcoholic hepatitis should be advised to maintain total abstinence from alcohol.
Hepatology
, 67
(6)
pp. 2479-2480.
10.1002/hep.29825.
|
Atkinson, SR;
Way, MJ;
McQuillin, A;
Morgan, MY;
Thursz, MR;
(2018)
Reply to: "The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population-based cohort".
Journal of Hepatology
, 68
(4)
pp. 860-862.
10.1016/j.jhep.2017.12.005.
|
Atkinson, SR;
Way, MJ;
McQuillin, A;
Morgan, MY;
Thursz, MR;
(2017)
Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis.
Journal of Hepatology
, 67
(1)
pp. 120-127.
10.1016/j.jhep.2017.01.018.
|
Balasus, D;
Way, M;
Fusilli, C;
Mazza, T;
Morgan, MY;
Cervello, M;
Giannitrapani, L;
... Montalto, G; + view all
(2016)
The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population.
Oncotarget
, 7
(52)
pp. 86791-86802.
10.18632/oncotarget.13558.
|
Bjerring, PN;
Morgan, MY;
Vilstrup, H;
Nielsen, SM;
Christensen, R;
Gluud, LL;
(2018)
Medical interventions for prevention and treatment of hepatic encephalopathy in adults with cirrhosis: A network meta-analysis.
Cochrane Database of Systematic Reviews
(12)
, Article CD013241. 10.1002/14651858.CD013241.
|
Buch, S;
Sharma, A;
Ryan, E;
Datz, C;
Griffiths, WJH;
Way, M;
Buckley, TWM;
... Morgan, MY; + view all
(2021)
Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosis.
Alimentary Pharmacology & Therapeutics
, 53
(7)
pp. 830-843.
10.1111/apt.16252.
|
Buch, Stephan;
Innes, Hamish;
Lutz, Philipp Ludwig;
Nischalke, Hans Dieter;
Marquardt, Jens U;
Fischer, Janett;
Weiss, Karl Heinz;
... Stickel, Felix; + view all
(2022)
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.
Gut
10.1136/gutjnl-2022-327196.
(In press).
|
De Silva, R;
Negus, R;
Morgan, MY;
(2019)
The appropriateness of current UK training in acute internal medicine.
Acute Medicine
, 18
(3)
pp. 148-157.
|
Gluud, LL;
Jeyaraj, R;
Morgan, MY;
(2019)
Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy.
Journal of Clinical and Experimental Hepatology
10.1016/j.jceh.2019.02.004.
|
Gluud, LL;
Morgan, MY;
(2017)
Endoscopic therapy and beta-blockers for secondary prevention in adults with cirrhosis and oesophageal varices.
Cochrane Database of Systematic Reviews
(6)
, Article CD012694. 10.1002/14651858.CD012694.
|
Gluud, LL;
Vilstrup, H;
Morgan, MY;
(2016)
Non-Absorbable Disaccharides for Hepatic Encephalopathy: A Systematic Review and Meta-Analysis.
Hepatology
, 64
(3)
pp. 908-922.
10.1002/hep.28598.
|
Gluud, LL;
Vilstrup, H;
Morgan, MY;
(2016)
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Cochrane Database of Systematic Reviews
(5)
, Article CD003044. 10.1002/14651858.CD003044.pub4.
|
Gluud, LL;
Vilstrup, H;
Morgan, MY;
(2016)
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS
(4)
, Article CD003044. 10.1002/14651858.CD003044.pub3.
|
Goh, ET;
Andersen, ML;
Morgan, MY;
Gluud, LL;
(2017)
Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.
Cochrane Database of Systematic Reviews
, 8
, Article CD002798. 10.1002/14651858.CD002798.pub4.
|
Goh, ET;
Andersen, ML;
Morgan, MY;
Gluud, LL;
(2017)
Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy.
[Review].
Cochrane Database of Systematic Review
, 7
, Article CD002798. 10.1002/14651858.CD002798.pub3.
|
Goh, ET;
Morgan, MY;
(2017)
Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore.
Alimentary Pharmacology & Therapeutics
, 45
(7)
pp. 865-882.
10.1111/apt.13965.
|
Goh, ET;
Stokes, CS;
Sidhu, SS;
Vilstrup, H;
Gluud, LL;
Morgan, MY;
(2018)
L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Cochrane Database Syst Rev
, 5
, Article CD012410. 10.1002/14651858.CD012410.pub2.
|
Grover, VP;
McPhail, MJ;
Wylezinska-Arridge, M;
Crossey, MM;
Fitzpatrick, JA;
Southern, L;
Saxby, BK;
... Taylor-Robinson, SD; + view all
(2016)
A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy.
Metabolic Brain Disease
, 32
(1)
pp. 77-86.
10.1007/s11011-016-9881-3.
|
Grover, VPB;
Crossey, MME;
Fitzpatrick, JA;
Saxby, BK;
Shaw, R;
Waldman, AD;
Morgan, MY;
(2016)
Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study.
Metabolic Brain Disease
, 31
(6)
pp. 1315-1325.
10.1007/s11011-015-9716-7.
|
Innes, Hamish;
Morgan, Marsha Y;
Hampe, Jochen;
Stickel, Felix;
Buch, Stephan;
(2023)
The rs72613567:TA polymorphism in HSD17B13 is associated with survival benefit after development of hepatocellular carcinoma.
Alimentary Pharmacology and Therapeutics
10.1111/apt.17638.
(In press).
|
Innes, H;
Buch, S;
Hutchinson, S;
Guha, IN;
Morling, JR;
Barnes, E;
Irving, W;
... Stickel, F; + view all
(2020)
Genome-wide Association Study for Alcohol-related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1.
Gastroenterology
, 159
(4)
1276-1289.e7.
10.1053/j.gastro.2020.06.014.
|
Kajihara, M;
Montagnese, S;
Khanna, P;
Amodio, P;
Schapira, AHV;
Dusheiko, GM;
Morgan, MY;
(2010)
Parkinsonism in patients with chronic hepatitis C treated with interferon-alpha 2b: a report of two cases.
European Journal of Gastroenterology & Hepatology
, 22
(5)
pp. 628-631.
10.1097/MEG.0b013e32833383e3.
|
Kalafateli, M;
Mantzoukis, K;
Choi Yau, Y;
Mohammad, AO;
Arora, S;
Rodrigues, S;
de Vos, M;
... Tsochatzis, EA; + view all
(2017)
Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score.
Journal of Cachexia, Sarcopenia and Muscle
, 8
(1)
pp. 113-121.
10.1002/jcsm.12095.
|
Lanthier, PL;
Morgan, MY;
Ballantyne, J;
(1984)
Bromocriptine-associated ototoxicity.
Journal of Laryngology and Otology
, 98
(4)
399 - 404.
10.1017/S0022215100146808.
|
Li, W;
Thygesen, JH;
O'Brien, NL;
Heydtmann, M;
Smith, I;
Degenhardt, F;
Nöthen, MM;
... McQuillin, A; + view all
(2021)
The influence of regression models on genome-wide association studies of alcohol dependence: a comparison of binary and quantitative analyses.
Psychiatric Genetics
, 31
(1)
pp. 13-20.
10.1097/YPG.0000000000000268.
|
Limon-Miro, Ana Teresa;
Jackson, Clive Douglas;
Eslamparast, Tannaz;
Yamanaka-Okumura, Hisami;
Plank, Lindsay Dudley;
Henry, Christiani Jeyakumar;
Madden, Angela Mary;
... Morgan, Marsha Yvonne; + view all
(2022)
Predicted estimates of resting energy expenditure have limited clinical utility in patients with cirrhosis.
Journal of Hepatology
, 77
(1)
pp. 98-107.
10.1016/j.jhep.2022.01.005.
|
Madden, AM;
Morgan, MY;
(1999)
Patterns of energy intake in patients with cirrhosis and healthy volunteers.
BRIT J NUTR
, 82
(1)
41 - 48.
10.1017/S0007114599001105.
|
Martinez Garcia de la Torre, Raquel A;
Vallverdu, Julia;
Xu, Zhenqing;
Arino, Silvia;
Ferrer-Lorente, Raquel;
Zanatto, Laura;
Mercado-Gomez, Maria;
... Sancho-Bru, Pau; + view all
(2025)
Trajectory analysis of hepatic stellate cell differentiation reveals metabolic regulation of cell commitment and fibrosis.
Nature Communications
, 16
(1)
, Article 1489. 10.1038/s41467-025-56024-4.
|
McCabe, WA;
Way, MJ;
Ruparelia, K;
Knapp, S;
Ali, MA;
Anstee, QM;
Thomas, HC;
... Morgan, MY; + view all
(2017)
Genetic variation in GABRβ1 and the risk for developing alcohol dependence.
Psychiatric Genetics
, 27
(3)
pp. 110-115.
10.1097/YPG.0000000000000169.
|
Montagnese, S;
Gordon, HM;
Jackson, C;
Smith, J;
Tognella, P;
Jethwa, N;
Sherratt, RM;
(2005)
Disruption of smooth pursuit eye movements in cirrhosis: relationship to hepatic encephalopathy and its treatment.
Hepatology
, 42
(4)
pp. 772-781.
10.1002/hep.20855.
|
Morgan, MY;
Sharma, M;
Atkinson, SR;
(2021)
Genetic and Environmental Susceptibility to Alcoholic Hepatitis.
Clinics in Liver Disease
, 25
(3)
pp. 517-535.
10.1016/j.cld.2021.04.001.
|
Morgan, MY;
(2016)
Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.
Metabolic Brain Disease
, 31
(6)
pp. 1361-1364.
10.1007/s11011-016-9910-2.
|
Ndiaye, H;
Liu, J;
Hall, A;
Minogue, S;
Morgan, M;
Waugh, MG;
(2020)
Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.
Bioscience Reports
, 40
(4)
, Article BSR20200219. 10.1042/BSR20200219.
|
O'Brien, Niamh L;
Quadri, Giorgia;
Lightley, Iain;
Sharp, Sally;
Guerrini, Irene;
Smith, Iain;
Heydtmann, Mathis;
... McQuillin, Andrew; + view all
(2022)
SLC19A1 Genetic Variation Leads to Altered Thiamine Diphosphate Transport: Implications for the Risk of Developing Wernicke-Korsakoff's Syndrome.
Alcohol and Alcoholism
, 57
(5)
pp. 581-588.
10.1093/alcalc/agac032.
|
O'Brien, NL;
Way, MJ;
Kandaswamy, R;
Fiorentino, A;
Sharp, SI;
Quadri, G;
Alex, J;
... McQuillin, A; + view all
(2014)
The functional GRM3 Kozak sequence variant rs148754219 affects the risk of schizophrenia and alcohol dependence as well as bipolar disorder.
Psychiatr Genet
, 24
(6)
277 - 278.
10.1097/YPG.0000000000000050.
|
Oleribe, OO;
Taylor-Robinson, AW;
Nwanyanwu, OC;
Morgan, MY;
Taylor-Robinson, SD;
(2024)
Four Years Since COVID-19 Day Zero: A Time to Evaluate Past and Future Pandemic Control Policies and Practices in Sub-Saharan Africa?
Risk Management and Healthcare Policy
, 17
pp. 505-511.
10.2147/RMHP.S449701.
|
Olesen, SS;
Gram, M;
Jackson, CD;
Halliday, E;
Sandberg, TH;
Drewes, AM;
Morgan, MY;
(2016)
Electroencephalogram variability in patients with cirrhosis associates with the presence and severity of hepatic encephalopathy.
Journal of Hepatology
, 65
(3)
pp. 517-523.
10.1016/j.jhep.2016.05.004.
|
Olesen, SS;
Jackson, CD;
Gram, M;
Zacharias, HD;
Dirks, M;
Weissenborn, K;
Drewes, AM;
(2019)
Cortical networks are disturbed in people with cirrhosis even in the absence of neuropsychometric impairment.
Clinical Neurophysiology
, 130
(3)
pp. 419-427.
10.1016/j.clinph.2018.11.011.
|
Olesen, SS;
Jackson, CD;
Morgan, MY;
(2017)
Tools and tactics for improving diagnosis of hepatic encephalopathy.
Journal of Hepatology
, 66
(6)
pp. 1327-1328.
10.1016/j.jhep.2017.01.034.
|
Orlien, SMS;
Berhe, NB;
Morgan, MY;
Johannessen, A;
(2019)
Khat-related liver disease in sub-Saharan Africa: neglected, yet important.
[Letter].
Lancet Global Health
, 7
(3)
e310.
10.1016/S2214-109X(18)30527-8.
|
Orlien, SMS;
Ismael, NY;
Ahmed, TA;
Berhe, N;
Lauritzen, T;
Roald, B;
Goldin, RD;
... Johannessen, A; + view all
(2018)
Unexplained chronic liver disease in Ethiopia: a cross-sectional study.
BMC Gastroenterology
, 18
, Article 27. 10.1186/s12876-018-0755-5.
|
Orlien, SMS;
Sandven, I;
Belay Berhe, N;
Ismael, NY;
Ahmed, TA;
Stene-Johansen, K;
Gundersen, SG;
... Johannessen, A; + view all
(2018)
Khat chewing increases the risk for developing chronic liver disease: A hospital-based case-control study.
Hepatology
, 68
(1)
pp. 248-257.
10.1002/hep.29809.
|
Quadri, G;
McQuillin, A;
Guerrini, I;
Thomson, AD;
Cherian, R;
Saini, J;
Ruparelia, K;
... Gurling, HM; + view all
(2014)
Evidence for genetic susceptibility to the alcohol dependence syndrome from the thiamine transporter 2 gene solute carrier SLC19A3.
Psychiatr Genet
, 24
(3)
pp. 122-123.
10.1097/YPG.0000000000000025.
|
Schwantes-An, Tae-Hwi;
Whitfield, John B;
Aithal, Guruprasad P;
Atkinson, Stephen R;
Bataller, Ramon;
Botwin, Greg;
Chalasani, Naga P;
... GenomALC, Consortium; + view all
(2024)
A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry.
Hepatology Communications
, 8
(6)
, Article e0431. 10.1097/HC9.0000000000000431.
|
Sharp, SI;
McQuillin, A;
Marks, M;
Hunt, SP;
Stanford, SC;
Lydall, GJ;
Morgan, MY;
... Gurling, HM; + view all
(2014)
Genetic association of the tachykinin receptor 1 TACR1 gene in bipolar disorder, attention deficit hyperactivity disorder, and the alcohol dependence syndrome.
Am J Med Genet B Neuropsychiatr Genet
, 165
(4)
pp. 373-380.
10.1002/ajmg.b.32241.
|
Stickel, F;
Buch, S;
Nischalke, HD;
Weiss, KH;
Gotthardt, D;
Fischer, J;
Rosendahl, J;
... Hampe, J; + view all
(2018)
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
The American Journal of Gastroenterology
10.1038/s41395-018-0041-8.
(In press).
|
Stickel, F;
Lutz, P;
Buch, S;
Nischalke, HD;
Silva, I;
Rausch, V;
Fischer, J;
... Morgan, MY; + view all
(2020)
Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers.
Hepatology
, 72
(1)
pp. 88-102.
10.1002/hep.30996.
|
Stickel, F;
Moreno, C;
Hampe, J;
Morgan, MY;
(2017)
The genetics of alcohol dependence and alcohol-related liver disease.
Journal of Hepatology
, 66
(1)
pp. 195-211.
10.1016/j.jhep.2016.08.011.
|
Stickel, F;
Morgan, MY;
(2020)
Predicting long-term prognosis in severe alcoholic hepatitis.
Liver International
, 40
(3)
pp. 511-513.
10.1111/liv.14343.
|
Stokes, CS;
Goh, ET;
Vilstrup, H;
Morgan, MY;
Gluud, LL;
(2016)
L-ornithine L-aspartate for people with cirrhosis and hepatic encephalopathy.
Cochrane Database of Systematic Reviews
, 2016
(10)
, Article CD012410. 10.1002/14651858.CD012410.
|
Strnad, P;
Buch, S;
Hamesch, K;
Fischer, J;
Rosendahl, J;
Schmelz, R;
Brueckner, S;
... Trautwein, C; + view all
(2018)
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis.
Gut
10.1136/gutjnl-2018-316228.
|
Taylor-Robinson, SD;
Morgan, MY;
Olupot-Olupot, P;
Taylor-Robinson, AW;
(2022)
Societal Reopening After the COVID-19 Pandemic.
Public Health
, 205
e5.
10.1016/j.puhe.2021.09.037.
|
Taylor-Robinson, Simon D;
Morgan, Marsha Y;
(2023)
COVID-19 and the Liver: A Complex and Evolving Picture.
Hepatic Medicine: Evidence and Research
, 15
pp. 209-220.
10.2147/HMER.S384172.
|
Taylor-Robinson, Simon D;
Morgan, Marsha Y;
Spearman, C Wendy;
Suliman, Ahmed AA;
Corrah, Tumani;
Oleribe, Obinna O;
Taylor-Robinson, Andrew W;
(2022)
Why SARS-CoV-2 Vaccination Still Matters in Africa.
QJM: An International Journal of Medicine
, 115
(3)
pp. 191-192.
10.1093/qjmed/hcac014.
|
Vadera, S;
Greenslade, L;
Morgan, MY;
(2016)
Health-Related Quality of Life, Psychological Well-Being and Socioeconomic Impact in Patients With Cirrhosis and Their Caregivers.
Gut
, 65
(Suppl 1)
A274-A274.
10.1136/gutjnl-2016-312388.516.
|
Vadera, S;
Yong, CWK;
Gluud, LL;
Morgan, MY;
(2019)
Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices.
Cochrane Database of Systematic Reviews
, 6
, Article CD012673. 10.1002/14651858.CD012673.pub2.
|
Way, MJ;
Ali, MA;
McQuillin, A;
Morgan, MY;
(2017)
Genetic variants in ALDH1B1 and alcohol dependence risk in a British and Irish population: A bioinformatic and genetic study.
PLoS One
, 12
(6)
, Article e0177009. 10.1371/journal.pone.0177009.
|
Whitfield, JB;
Schwantes-An, T-H;
Darlay, R;
Aithal, GP;
Atkinson, SR;
Bataller, R;
Botwin, G;
... Seth, D; + view all
(2022)
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers.
Journal of Hepatology
, 76
(2)
pp. 275-282.
10.1016/j.jhep.2021.10.005.
|
Whitfield, JB;
Seth, D;
Morgan, TR;
Aithal, GP;
Atkinson, SR;
Bataller, R;
Botwin, G;
... Trepo, E; + view all
(2022)
All-cause and liver-related mortality risk factors in excessive drinkers: Analysis of data from the UK biobank.
Alcoholism: Clinical and Experimental Research
10.1111/acer.14968.
(In press).
|
Yong, CWK;
Vadera, S;
Morgan, MY;
Gluud, LL;
(2017)
Banding ligation versus no intervention for primary prevention in adults with oesophageal varices.
Cochrane Database of Systematic Reviews
(5)
, Article CD012673. 10.1002/14651858.CD012673.
|
Zacharias, Harry D;
Kamel, Fady;
Tan, Jaclyn;
Kimer, Nina;
Gluud, Lise Lotte;
Morgan, Marsha Y;
(2023)
Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Cochrane Database of Systematic Reviews
, 2023
(7)
, Article CD011585. 10.1002/14651858.CD011585.pub2.
|
Zacharias, AP;
Jeyaraj, R;
Hobolth, L;
Bendtsen, F;
Gluud, LL;
Morgan, MY;
(2018)
Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
Cochrane Database of Systematic Reviews
, 10
, Article CD011510. 10.1002/14651858.CD011510.pub2.
|
Zacharias, HD;
Jackson, CD;
Morgan, MY;
Olesen, SS;
(2017)
Letter: stepwise diagnosis in covert hepatic encephalopathy - critical flicker frequency and MELD-score as a first-step approach. Replication and pitfalls.
Alimentary Pharmacology and Therapeutics
, 45
(1)
pp. 187-189.
10.1111/apt.13830.
|
Zacharias, HD;
Zacharias, AP;
Gluud, LL;
Morgan, MY;
(2019)
Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
Cochrane Database of Systematic Reviews
, 6
, Article CD012334. 10.1002/14651858.CD012334.pub2.
|
Zacharias, HD;
Zacharias, AP;
Oliveira Ferreira, A;
Morgan, MY;
Gluud, LL;
(2016)
Ammonia scavenging agents for people with cirrhosis and hepatic encephalopathy.
Cochrane Database of Systematic Reviews
, 2016
(8)
, Article CD012334. 10.1002/14651858.CD012334.
|
Zhou, H;
Sealock, JM;
Sanchez-Roige, S;
Clarke, T-K;
Levey, DF;
Cheng, Z;
Li, B;
... Gelernter, J; + view all
(2020)
Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits.
Nature Neuroscience
, 23
pp. 809-818.
10.1038/s41593-020-0643-5.
|
Proceedings paper
Atkinson, SR;
Forlano, R;
Manousou, P;
Grove, J;
Aithal, G;
McQuillin, A;
Quaglia, A;
... Morgan, MY; + view all
(2017)
Carriage of RS738409 in PNPLA3 is positively associated with the severity of histological damage in patients with alcoholic hepatitis.
In:
Abstracts of the 16th Congress of European Society for Biomedical Research on Alcoholism (ESBRA).
(pp. i31-i49).
Oxford University Press: Heraklion, Greece.
|
Report
|
Brown, A;
Copello, A;
Day, E;
Dervan, J;
Drummond, C;
Fry, J;
Gilman, M;
+ view all
(2011)
Alcohol Dependence and Harmful Alcohol use: Draft quality standard.
National Institute for Health and Care Excellence (NICE)
|
Conference item
Atkinson, S;
Way, M;
McQuillin, A;
Morgan, MY;
Thursz, M;
(2017)
Drinking behaviour and rs738409:g in pnpla3 are associated with slower recovery of liver function following severe alcoholic hepatitis.
Presented at: British Society of Gastroenterology Annual General Meeting 2017, Manchester, UK.
|
Cemente, A;
Atkinson, S;
Tyson, LD;
Ventura Cots, M;
Argemi, J;
Vergis, N;
Manimaran, S;
... Bataller, R; + view all
(2020)
Early alcohol relapse after an episode of alcohol-induced hepatitis (AH): prevalence, impact on liver function, genetic and non-genetic factors and identification of distinct risk profiles.
Presented at: Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Online.
|
Dhar, P;
Greenslade, L;
Westbrooke, R;
Jackson, CD;
Marshall, A;
Morgan, MY;
(2018)
PWE-084 Relationship between indices of frailty/disability with disease severity and nutritional status in patients with cirrhosis.
[Lecture].
Presented at: British Society of Gastroenterology (BSG) Annual Meeting 2018, Liverpool, UK.
|
Doshi, NC;
Mehta, G;
Chalmers, J;
Leena, KB;
Astbury, S;
Grove, JI;
McQuillin, A;
... Aithal, GP; + view all
(2020)
A genome-wide association study of non-alcoholic fatty liver disease in India: is there divergence in the genetic risk profile?
Presented at: Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Online.
|
Garcia-Garcia, R;
Morgan, MY;
Jackson, CD;
(2019)
Visual Analysis of the EEG Performs Better Than Standard Spectral Analysis in the Clinical Setting.
Presented at: 18th International Society for Hepatic Encephalopathy and Nitrogen Metabolism Meeting, Williamsburg, Virginia.
|
Huang, Yiwen;
Guerrini, Irene;
Smith, Iain;
Heydtmann, Mathis;
Morgan, Marsha;
Thomson, Allan;
Bass, Nicholas;
(2024)
Genetic Risk Factors for Developing Wernicke-Korsakoff Syndrome (WKS) in an Alcohol-Dependence Cohort: A Polygenic Risk Score Analysis of Serum Vitamin Concentrations and Dementia Subtype.
Presented at: 57th European Society of Human Genetics (ESHG) Conference, Berlin, Germany.
|
Jackson, CD;
Marks, M;
Morgan, MY;
(2019)
Optimizing the Performance of the Psychometric Hepatic Encephalopathy Score (PHES) for the Diagnosis of Hepatic Encephalopathy.
Presented at: 18th International Society for Hepatic Encephalopathy and Nitrogen Metabolism Meeting, Williamsburg, Virginia.
|
Jeyaraj, R;
Vadera, S;
Low, ZY;
Gluud, LL;
Morgan, MY;
(2019)
Aminoglycosides and Metronidazole for the Prevention and Treatment of Hepatic Encephalopathy in Adults With Cirrhosis.
Presented at: 18th International Society for Hepatic Encephalopathy and Nitrogen Metabolism Meeting, Williamsburg, Virginia.
|
Limon-Miro, AT;
Jackson, CD;
Eslamparast, T;
Yamanaka-Okumura, H;
Plank, LD;
Henry, CJ;
Madden, AM;
... Tandon, P; + view all
(2021)
Resting energy expenditure in patients with cirrhosis: an individual patient data meta-analysis of indirect calorimetry versus established and derived prediction equations.
Presented at: AASLD - The Liver Meeting 2021, Virtual.
|
Limon-Miro, AT;
Jackson, CD;
Eslamparast, T;
Yamanaka-Okumura, H;
Plank, LD;
Henry, CJ;
Madden, AM;
... Tandon, P; + view all
(2021)
Validity of current recommended daily energy intakes in people with cirrhosis based on individual patient data.
Presented at: AASLD - The Liver Meeting 2021, Virtual.
|
Ryan, JM;
Adams, HL;
Devshi, D;
Atkinson, S;
Tyson, L;
Shawcross, DL;
Wright, G;
... Chokshi, S; + view all
(2021)
OS-2158
Interferon lambda 4 is associated with dysfunctional antibacterial immunity during alcohol-related liver disease.
Presented at: The International Liver Congress June, Online.
|
Stickel, F;
Buch, S;
Rosendahl, J;
Nischalke, H-D;
Lammert, F;
Casper, M;
Vogel, A;
... Morgan, MY; + view all
(2018)
OWE-016 Genetic variants in PNPLA3 and TM6SF2 predispose to hepatocellular carcinoma in patients with alcohol-related cirrhosis.
[Lecture].
Presented at: British Society of Gastroenterology (BSG) Annual Meeting 2018, Liverpool, UK.
|
Zacharias, HD;
Zacharias, AP;
Gluud, LL;
Morgan, MY;
(2019)
Pharmacotherapies that Specifically Target Ammonia for the Prevention and Treatment of Hepatic Encephalopathy in Adults With Cirrhosis.
Presented at: 18th International Society for Hepatic Encephalopathy and Nitrogen Metabolism Meeting, Williamsburg, Virginia.
|
Thesis
McCabe, William Albert;
(2020)
The role of PNPLA3 in the development and progression of chronic liver injury.
Doctoral thesis (Ph.D), UCL (University College London).
|